JPRN-UMIN000017605已完成未知
Optimal combination of plasma filters in therapeutic double filtration plasmapheresis fo in kidney transplant recipients with higher immunological barrier - Optimal combination of plasma filters in therapeutic double filtration plasmapheresis fo in kidney transplant recipients with higher immunological barrier
Hokkaido University Graduate School of Medicine0 个研究点目标入组 13 人开始时间: 2015年5月18日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 13
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. kidney transplant candidates who experienced any unpredictable adverse events. 2. those recipients who don't have informed consents. 3. Those recipients whom the principal investigator judged as inappropriate candidates for the study.
研究者
相似试验
进行中（未招募）
不适用
Analysis of TPE Treatments With multiFiltratePROAutoimmune DiseasesNCT06272084Fresenius Medical Care Deutschland GmbH60
已完成
不适用
COMbining Plasmafiltration and Adsorption Clinical Trial: efficacy and safety of coupled plasma filtration adsorption for septic shock in the intensive care unitInfections and InfestationsOther septicaemiaSeptic shockISRCTN24534559Italian Group for the Evaluation of Interventions in Intensive Care Medicine (GiViTI)330
招募中
不适用
Clinical Performance of the New Plasma Filter PX2 in TPE TreatmentsAutoimmune DiseasesNCT06382675Fresenius Medical Care Deutschland GmbH46
尚未招募
不适用
Determination of therapeutic and toxic plasma concentrations of the antipsychotic drug prothipendylsedative agent within psychotic diseasesDRKS00011452Rechtsmedizin Bonn100
已完成
不适用
Performance Evaluation of plasma fraction filter FRACTIOsmart L in comparison to the Cascadeflo EC 50 in regular lipoprotein apheresis settingHypercholesteremiaDRKS00025297Kaneka Pharma Europe NV6